| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 23 | +47.83% | +1.39% | +0.63% | +0.76% | -0.60% | — |
| 14d | 23 | +52.17% | +2.34% | +1.01% | +1.33% | -0.73% | — |
| 30d | 23 | +43.48% | +1.72% | +1.50% | +0.45% | +1.92% | — |
| 60d | 23 | +43.48% | +1.83% | +5.34% | -3.96% | -4.97% | — |
| 90d | 23(1 pending) | +63.64% | -5.63% | +5.54% | -12.93% | -12.19% | — |
| 180d | 23(6 pending) | +94.12% | -27.11% | +13.03% | -40.13% | -45.43% | — |
| 1y | 23(9 pending) | +42.86% | -12.00% | +31.40% | -43.40% | -34.24% | — |
| 2y | 23(11 pending) | +100.00% | -42.63% | +31.93% | -74.56% | -64.33% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 4,653 | $23.77 | $110.6K | 105,689 | Jun 1, 2026 | Jun 1, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 4,683 | $24.90 | $116.6K | 110,342 | May 1, 2026 | May 4, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 59,952 | — | — | 59,952 | Apr 16, 2026 | Apr 20, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 34,674 | — | — | 115,025 | Apr 16, 2026 | Apr 20, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 4,683 | $20.97 | $98.2K | 80,351 | Apr 1, 2026 | Apr 2, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 1,635 | $22.40 | $36.6K | 85,034 | Mar 3, 2026 | Mar 3, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 5,290 | $22.80 | $120.6K | 89,788 | Mar 2, 2026 | Mar 3, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 3,119 | $22.54 | $70.3K | 86,669 | Mar 2, 2026 | Mar 3, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 6,143 | — | — | 95,078 | Mar 1, 2026 | Mar 3, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 3,061 | $23.56 | $72.1K | 88,935 | Feb 2, 2026 | Feb 3, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 3,150 | $22.84 | $71.9K | 91,996 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE10b5-1 10b5-1 plan | 3,081 | $36.38 | $112.1K | 95,146 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE Chief Financial Officer | 7,942 | $31.51 | $250.3K | 98,227 | Oct 13, 2025 | Oct 14, 2025 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE Chief Financial Officer | 1,785 | $40.40 | $72.1K | 106,169 | Mar 6, 2025 | Mar 10, 2025 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 28,160 | — | — | 28,160 | Mar 1, 2025 | Mar 4, 2025 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 15,653 | — | — | 107,954 | Mar 1, 2025 | Mar 4, 2025 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE Chief Financial Officer | 7,465 | $52.76 | $393.9K | 92,301 | Oct 10, 2024 | Oct 11, 2024 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 34,200 | — | — | 34,200 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 19,400 | — | — | 99,766 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 80,366 | — | — | 80,336 | Oct 9, 2023 | Oct 10, 2023 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 140,469 | — | — | 140,469 | Oct 9, 2023 | Oct 10, 2023 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 2,248 | $25.97 | $58.4K | 230,712 | Feb 23, 2023 | Feb 24, 2023 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 2,424 | $25.29 | $61.3K | 232,960 | Feb 17, 2023 | Feb 21, 2023 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Feb 22, 2022 | Feb 24, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 235,384 | Feb 22, 2022 | Feb 24, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 2,393 | $31.93 | $76.4K | 200,384 | Feb 17, 2022 | Feb 18, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Feb 16, 2021 | Feb 18, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 202,777 | Feb 16, 2021 | Feb 18, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 30,000 | $50.06 | $1.50M | 177,777 | Jul 13, 2020 | Jul 15, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 10,000 | $40.00 | $400.0K | 207,777 | Jul 2, 2020 | Jul 2, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 400 | $39.33 | $15.7K | 217,777 | Jul 1, 2020 | Jul 2, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 500 | $38.78 | $19.4K | 218,177 | Jul 1, 2020 | Jul 2, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 9,100 | $37.72 | $343.3K | 218,677 | Jul 1, 2020 | Jul 2, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 30,000 | $50.00 | $1.50M | 227,777 | Jun 25, 2020 | Jun 26, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 10,000 | $40.00 | $400.0K | 257,777 | Jun 19, 2020 | Jun 23, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 6,714 | $35.38 | $237.6K | 267,777 | Jun 1, 2020 | Jun 2, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE CFO | 3,286 | $34.53 | $113.5K | 274,491 | Jun 1, 2020 | Jun 2, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Feb 25, 2020 | Feb 27, 2020 ↗ | View → |